Skip to main content

Sanofi-Aventis S.A. ADR(SNY-Q)

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low47.47
Day High47.93
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.


A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.


What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.


A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Press & news

Latest News

Why Provention Bio Stock Skyrocketed 256% This Week
Motley Fool - Thu Mar 16, 3:56PM CDT
Motley Fool
Thu Mar 16, 3:56PM CDT
Provention Bio is currently a partner of Sanofi. It should soon become a part of the big French drugmaker.
2 Top Biotech Stocks to Buy Right Now
Motley Fool - Wed Mar 15, 8:30AM CDT
Motley Fool
Wed Mar 15, 8:30AM CDT
These two companies are showering shareholders with market-topping payouts.
PROVENTION BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Provention Bio, Inc. - PRVB
Business Wire - Mon Mar 13, 6:24PM CDT
Business Wire
Mon Mar 13, 6:24PM CDT
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Provention Bio, Inc. (NasdaqGS: PRVB) to Sanofi (NasdaqGS: SNY). Under the terms of the...

Latest Articles